Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient.

The binding of oxygen to heme irons in hemoglobin promotes the binding of nitric oxide (NO) to cysteinebeta93, forming S-nitrosohemoglobin. Deoxygenation is accompanied by an allosteric transition in S-nitrosohemoglobin [from the R (oxygenated) to the T (deoxygenated) structure] that releases the NO group. S-nitrosohemoglobin contracts blood vessels and decreases cerebral perfusion in the R structure and relaxes vessels to improve blood flow in the T structure. By thus sensing the physiological oxygen gradient in tissues, hemoglobin exploits conformation-associated changes in the position of cysteinebeta93 SNO to bring local blood flow into line with oxygen requirements.

[1]  A. Guyton,et al.  Textbook of Medical Physiology , 1961 .

[2]  R. Berne,et al.  Longitudinal Gradients in Periarteriolar Oxygen Tension: A Possible Mechanism For the Participation of Oxygen in Local Regulation of Blood Flow , 1970, Circulation research.

[3]  E. Braunwald.  Heart Disease: A Textbook of Cardiovascular Medicine , 1992, Annals of Internal Medicine.

[4]  W. Heiss,et al.  Comparison Between Hydrogen Clearance and Microsphere Techniquefor rCBF Measurement , 1981, Stroke.

[5]  S. Moncada,et al.  Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo , 1990, British journal of pharmacology.

[6]  J. Stamler,et al.  S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[7]  S. Gross,et al.  Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites. , 1992, Circulation research.

[8]  S. Archer,et al.  Chronic EDRF inhibition and hypoxia: effects on pulmonary circulation and systemic blood pressure. , 1993, Journal of applied physiology.

[9]  M. J. Winn,et al.  Canine hindlimb blood flow and O2 uptake after inhibition of EDRF/NO synthesis. , 1994, Journal of applied physiology.

[10]  J F Gross,et al.  Determination of local oxygen consumption rates in tumors. , 1994, Cancer research.

[11]  J. Edelsberg,et al.  Hyperbaric-oxygen therapy. , 1996, The New England journal of medicine.

[12]  J. Stamler,et al.  S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control , 1996, Nature.

[13]  J. Rodés,et al.  Increased blood hemoglobin attenuates splanchnic vasodilation in portal-hypertensive rats by nitric oxide inactivation. , 1996, Gastroenterology.

[14]  M. Intaglietta,et al.  pO2Measurements in Arteriolar Networks , 1996 .

[15]  J. Stamler.  Alzheimer's disease. A radical vascular connection. , 1996, Nature.

[16]  R. Winslow,et al.  Microvascular and tissue oxygen distribution. , 1996, Cardiovascular research.

[17]  W. Buzello,et al.  Effects of a Hemoglobin-Based Oxygen Carrier (HBOC-201) on Hemodynamics and Oxygen Transport in Patients Undergoing Preoperative Hemodilution for Elective Abdominal Aortic Surgery , 1996, Anesthesia and analgesia.

[18]  C. Piantadosi,et al.  Production of hydroxyl radical in the hippocampus after CO hypoxia or hypoxic hypoxia in the rat. , 1997, Free radical biology & medicine.